| Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial M Matucci-Cerinic, CP Denton, DE Furst, MD Mayes, VM Hsu, ... Annals of the rheumatic diseases 70 (1), 32-38, 2011 | 572 | 2011 |
| The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool MA Judson, U Costabel, M Drent, A Wells, L Maier, L Koth, H Shigemitsu, ... Sarcoidosis Vasc Diffuse Lung Dis 31 (1), 19-27, 2014 | 450 | 2014 |
| Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo‐controlled, dose … MC Genovese, JL Kaine, MB Lowenstein, JD Giudice, A Baldassare, ... Arthritis & Rheumatism 58 (9), 2652-2661, 2008 | 282 | 2008 |
| Racial difference in sarcoidosis mortality in the United States M Mirsaeidi, RF Machado, D Schraufnagel, NJ Sweiss, RP Baughman Chest 147 (2), 438-449, 2015 | 214 | 2015 |
| Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating … JP Cremers, M Drent, A Bast, H Shigemitsu, RP Baughman, D Valeyre, ... Current Opinion in Pulmonary Medicine 19 (5), 545-561, 2013 | 200 | 2013 |
| Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance G Murtagh, LJ Laffin, JF Beshai, F Maffessanti, CA Bonham, AV Patel, ... Circulation: Cardiovascular Imaging 9 (1), e003738, 2016 | 169 | 2016 |
| Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis JL Schuller, M Zipse, T Crawford, F Bogun, J Beshai, AR Patel, NJ Sweiss, ... Journal of cardiovascular electrophysiology 23 (9), 925-929, 2012 | 147 | 2012 |
| Rituximab in the treatment of refractory pulmonary sarcoidosis NJ Sweiss, EE Lower, M Mirsaeidi, S Dudek, JGN Garcia, D Perkins, ... European Respiratory Journal 43 (5), 1525-1528, 2014 | 146 | 2014 |
| Tocilizumab in the treatment of rheumatoid arthritis and beyond A Shetty, R Hanson, P Korsten, M Shawagfeh, S Arami, S Volkov, O Vila, ... Drug design, development and therapy, 349-364, 2014 | 138 | 2014 |
| MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial L Chung, L Shapiro, D Fiorentino, M Baron, J Shanahan, S Sule, V Hsu, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 138 | 2009 |
| Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations NJ Sweiss, R Salloum, S Ghandi, ML Alegre, R Sawaqed, M Badaracco, ... PLoS One 5 (2), e9088, 2010 | 135 | 2010 |
| Established and experimental medical therapy of pulmonary sarcoidosis RP Baughman, H Nunes, NJ Sweiss, EE Lower European Respiratory Journal 41 (6), 1424-1438, 2013 | 131 | 2013 |
| Ocrelizumab: a step forward in the evolution of B-cell therapy F Kausar, K Mustafa, G Sweis, R Sawaqed, K Alawneh, R Salloum, ... Expert opinion on biological therapy 9 (7), 889-895, 2009 | 131 | 2009 |
| Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis FF Rahaghi, RP Baughman, LA Saketkoo, NJ Sweiss, JB Barney, ... European respiratory review 29 (155), 2020 | 112 | 2020 |
| Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis NJ Sweiss, MJ Welsch, JJ Curran, MH Ellman Arthritis and Rheumatism-Arthritis Care and Research 53 (5), 788-791, 2005 | 106 | 2005 |
| Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis NJ Sweiss, I Noth, M Mirsaeidi, W Zhang, ET Naureckas, DK Hogarth, ... Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of …, 2014 | 105 | 2014 |
| Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study AR Patel, MR Klein, S Chandra, KT Spencer, JM DeCara, RM Lang, ... European journal of heart failure 13 (11), 1231-1237, 2011 | 104 | 2011 |
| Rheumatologic manifestations of sarcoidosis NJ Sweiss, K Patterson, R Sawaqed, U Jabbar, P Korsten, K Hogarth, ... Seminars in respiratory and critical care medicine 31 (04), 463-473, 2010 | 103 | 2010 |
| Management of extrapulmonary sarcoidosis: challenges and solutions K Al-Kofahi, P Korsten, C Ascoli, S Virupannavar, M Mirsaeidi, I Chang, ... Therapeutics and clinical risk management, 1623-1634, 2016 | 101 | 2016 |
| Calcium and vitamin D metabolism in sarcoidosis. RP Baughman, J Janovcik, M Ray, N Sweiss, EE Lower Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of …, 2013 | 101 | 2013 |
Peter KorstenUniversity Medicine Göttingen, Nephrology and Rheumatologymed.uni-goettingen.de üzerinde doğrulanmış e-posta adresine sahip
